TEL: (019467) 74716
Compensation Scheme Executive Secretariat, Sellafield Limited
Sellafield, Seascale, Cumbria CA20 1PG


The MOD / AWE CSMB Annual Progress Statement to Council 2018

This report from the Ministry of Defence (MOD) and Atomic Weapons Establishment (AWE) CSMB to the Compensation Scheme Council provides a brief description of MOD and AWE’s involvement within the Scheme. This includes the key issues considered by the CSMB during FY 2017-2018 and an update on the number of cases being dealt with under the Scheme.


Union Participation - The majority of claimants who are union members are members of Prospect, Unite or GMB.

MOD Operating sites - The MOD operates a number of MOD nuclear sites and submarines. The MOD also provides medical services (including medical X-ray), carries out a wide range of industrial radiography, operates RADAR equipment and uses radioactive materials to support operational requirements. MOD employees may also be exposed to environmental radiation sources in the course of their employment.

AWE provides the nuclear weapon deterrent and national nuclear security activities on behalf of MOD.

History within the Scheme and Working Arrangements

The MOD/AWE CSMB has now been operating for twenty three years. It met once between the 1 April 2017 and 1 April 2018 and sent employer representatives to the technical working party meeting held during this period.

Case Work

Since the formation of the board, there has been a total of 477 MOD/AWE cases received which have been eligible for detailed consideration by the Scheme. Twenty of these have qualified for compensation payments and have been settled, two are ongoing, one of which is close to resolution.

This board has received 14 new applications this financial year, none of which have been successful.

Active management of data requests for information required to support claims by both Dstl and the Institute of Naval medicine has resulted in a marked improvement in the key performance indicators on timescales for dealing with case work for MOD claims. However, complex issues and reliance on supply of information from external data providers delay approximately 10% of cases supported by DSTL/INM.

AWE has had no significant delays in collating data for external and internal dosimetry reports although there was one issue with the timeliness of obtaining a Certificate of Diagnosis. AWE continue to meet with their unions prior to the MoD/AWE Board.

Contribution to Scheme

Dstl has not significantly contributed to the scheme in the last financial year other than ensuring cases are processed within the appropriate timeframes. Effort has been focussed on managing the internal handover of the capability from the two retiring subject matter experts.